{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:48:19Z","timestamp":1792064899652,"version":"4.4.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-026-08398-y","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:14:49Z","timestamp":1784286889000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of memantine as adjunctive treatment for manic episodes in bipolar disorder (BD): a randomized, double-blind, placebo-controlled clinical trial"],"prefix":"10.1186","volume":"26","author":[{"given":"Hasan","family":"Mirzazadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erfan","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mostafavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrad","family":"Namazee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Hasani","family":"Ashourzade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6642-6803","authenticated-orcid":false,"given":"Reza","family":"Moshfeghinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayyeh","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"8398_CR1","doi-asserted-by":"publisher","unstructured":"Bipolar and related disorders. In: Diagnostic and statistical manual of mental disorders. 5th ed. Text Revision. American Psychiatric Association; 2022. Accessed 12 Sept 2023. https:\/\/doi.org\/10.1176\/appi.books.9780890425787.x03_Bipolar_and_Related_Disorders.","DOI":"10.1176\/appi.books.9780890425787.x03_Bipolar_and_Related_Disorders"},{"issue":"12","key":"8398_CR2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.5498\/wjp.v12.i12.1335","volume":"12","author":"S Chakrabarti","year":"2022","unstructured":"Chakrabarti S. Bipolar disorder in the International Classification of Diseases-Eleventh version: A review of the changes, their basis, and usefulness. World J Psychiatry. 2022;12(12):1335\u201355.","journal-title":"World J Psychiatry"},{"issue":"9","key":"8398_CR3","doi-asserted-by":"crossref","first-page":"e1259","DOI":"10.4088\/JCP.16r11165","volume":"78","author":"ALR Moreira","year":"2017","unstructured":"Moreira ALR, Van Meter A, Genzlinger J, Youngstrom EA. Review and Meta-Analysis of Epidemiologic Studies of Adult Bipolar Disorder. J Clin Psychiatry. 2017;78(9):e1259\u201369.","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 1","key":"8398_CR4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0165-0327(14)70003-5","volume":"169","author":"S Miller","year":"2014","unstructured":"Miller S, Dell\u2019Osso B, Ketter TA. The prevalence and burden of bipolar depression. J Affect Disord. 2014;169(Suppl 1):S3\u201311.","journal-title":"J Affect Disord"},{"issue":"1","key":"8398_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40345-017-0078-4","volume":"5","author":"LG Sylvia","year":"2017","unstructured":"Sylvia LG, Montana RE, Deckersbach T, Thase ME, Tohen M, Reilly-Harrington N, et al. Poor quality of life and functioning in bipolar disorder. Int J Bipolar Disord. 2017;5(1):10.","journal-title":"Int J Bipolar Disord"},{"issue":"14","key":"8398_CR6","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/jama.2023.18588","volume":"330","author":"AA Nierenberg","year":"2023","unstructured":"Nierenberg AA, Agustini B, K\u00f6hler-Forsberg O, Cusin C, Katz D, Sylvia LG, et al. Diagnosis and Treatment of Bipolar Disorder: A Review. JAMA. 2023;330(14):1370\u201380.","journal-title":"JAMA"},{"issue":"6","key":"8398_CR7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/bdi.12319","volume":"17","author":"JG Jackson","year":"2015","unstructured":"Jackson JG, Diaz FJ, Lopez L, de Leon J. A combined analysis of worldwide studies demonstrates an association between bipolar disorder and tobacco smoking behaviors in adults. Bipolar Disord. 2015;17(6):575\u201397.","journal-title":"Bipolar Disord"},{"issue":"6","key":"8398_CR8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/acps.12408","volume":"131","author":"JF Hayes","year":"2015","unstructured":"Hayes JF, Miles J, Walters K, King M, Osborn DP. A systematic review and meta-analysis of premature mortality in bipolar affective disorder. Acta Psychiatr Scand. 2015;131(6):417\u201325.","journal-title":"Acta Psychiatr Scand"},{"issue":"9","key":"8398_CR9","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamapsychiatry.2013.1394","volume":"70","author":"C Crump","year":"2013","unstructured":"Crump C, Sundquist K, Winkleby MA, Sundquist J. Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. JAMA Psychiatry. 2013;70(9):931\u20139.","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"8398_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11920-020-1130-0","volume":"22","author":"JN Miller","year":"2020","unstructured":"Miller JN, Black DW. Bipolar Disorder and Suicide: a Review. Curr Psychiatry Rep. 2020;22(2):6.","journal-title":"Curr Psychiatry Rep"},{"key":"8398_CR11","doi-asserted-by":"crossref","unstructured":"Malekpour M, Akbari M, Tafti MF, Falamarzi K, Golabi F, Meybodi MJE, et al. MicroRNAs and suicidality: a systematic review and bioinformatic evaluation. Front Psychiatry. 2026;17 - 2026.","DOI":"10.3389\/fpsyt.2026.1723187"},{"key":"8398_CR12","doi-asserted-by":"crossref","unstructured":"Oliva V, Fico G, De Prisco M, Gonda X, Rosa AR, Vieta E. Bipolar disorders: an update on critical aspects. Lancet Reg Health \u2013 Europe. 2025;48.","DOI":"10.1016\/j.lanepe.2024.101135"},{"issue":"1","key":"8398_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40345-019-0160-1","volume":"8","author":"RJ Baldessarini","year":"2020","unstructured":"Baldessarini RJ, V\u00e1zquez GH, Tondo L. Bipolar depression: a major unsolved challenge. Int J Bipolar Disord. 2020;8(1):1.","journal-title":"Int J Bipolar Disord"},{"issue":"12","key":"8398_CR14","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S2215-0366(16)30264-4","volume":"3","author":"A McGirr","year":"2016","unstructured":"McGirr A, V\u00f6hringer PA, Ghaemi SN, Lam RW, Yatham LN. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials. Lancet Psychiatry. 2016;3(12):1138\u201346.","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"8398_CR15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/acps.12343","volume":"130","author":"DM Taylor","year":"2014","unstructured":"Taylor DM, Cornelius V, Smith L, Young AH. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis. Acta Psychiatr Scand. 2014;130(6):452\u201369.","journal-title":"Acta Psychiatr Scand"},{"key":"8398_CR16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fpsyt.2013.00052","volume":"4","author":"SE Lakhan","year":"2013","unstructured":"Lakhan SE, Caro M, Hadzimichalis N. NMDA Receptor Activity in Neuropsychiatric Disorders. Front Psychiatry. 2013;4:52.","journal-title":"Front Psychiatry"},{"key":"8398_CR17","first-page":"1101","volume":"9","author":"KA Lapidus","year":"2013","unstructured":"Lapidus KA, Soleimani L, Murrough JW. Novel glutamatergic drugs for the treatment of mood disorders. Neuropsychiatr Dis Treat. 2013;9:1101\u201312.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"8398_CR18","first-page":"195","volume":"1053","author":"DM Chuang","year":"2005","unstructured":"Chuang DM. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials. Ann N Y Acad Sci. 2005;1053:195\u2013204.","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"8398_CR19","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","volume":"16","author":"W L\u00f6scher","year":"2002","unstructured":"L\u00f6scher W. Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs. 2002;16(10):669\u201394.","journal-title":"CNS Drugs"},{"key":"8398_CR20","unstructured":"Kuns B, Rosani A, Patel P, Varghese D. Memantine. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2025. StatPearls Publishing LLC; 2025."},{"issue":"12","key":"8398_CR21","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/nm1209-1355","volume":"15","author":"AR La Spada","year":"2009","unstructured":"La Spada AR. Memantine strikes the perfect balance. Nat Med. 2009;15(12):1355\u20136.","journal-title":"Nat Med"},{"issue":"8","key":"8398_CR22","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.biopsych.2008.05.014","volume":"64","author":"D \u00d6ng\u00fcr","year":"2008","unstructured":"\u00d6ng\u00fcr D, Jensen JE, Prescot AP, Stork C, Lundy M, Cohen BM, et al. Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol Psychiatry. 2008;64(8):718\u201326.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"8398_CR23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/JAD-2008-14207","volume":"14","author":"M Emre","year":"2008","unstructured":"Emre M, Mecocci P, Stender K. Pooled analyses on cognitive effects of memantine in patients with moderate to severe Alzheimer\u2019s disease. J Alzheimers Dis. 2008;14(2):193\u20139.","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"8398_CR24","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2165\/11634390-000000000-00000","volume":"26","author":"G Sani","year":"2012","unstructured":"Sani G, Serra G, Kotzalidis GD, Romano S, Tamorri SM, Manfredi G, et al. The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence. CNS Drugs. 2012;26(8):663\u201390.","journal-title":"CNS Drugs"},{"issue":"3","key":"8398_CR25","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41380-024-02705-3","volume":"30","author":"W Huang","year":"2025","unstructured":"Huang W, He S, Liu M, Xu J. Comparative efficacy, safety, and tolerability of pharmacotherapies for acute mania in adults: a systematic review and network meta-analysis of randomized controlled trials. Mol Psychiatry. 2025;30(3):838\u201347.","journal-title":"Mol Psychiatry"},{"key":"8398_CR26","doi-asserted-by":"crossref","unstructured":"Butler M, Urosevic S, Desai P, Sponheim SR, Popp J, Nelson VA, et al. Treatment for bipolar disorder in adults: a systematic review. 2018.","DOI":"10.23970\/AHRQEPCCER208"},{"issue":"1","key":"8398_CR27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.59.1.62","volume":"59","author":"M Tohen","year":"2002","unstructured":"Tohen M, Chengappa KR, Suppes T, Zarate CA, Calabrese JR, Bowden CL, et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry. 2002;59(1):62\u20139.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"8398_CR28","first-page":"175","volume":"6","author":"Z Mohammadi","year":"2018","unstructured":"Mohammadi Z, Pourshahbaz A, Poshtmashhadi M, Dolatshahi B, Barati F, Zarei M. Psychometric properties of the young mania rating scale as a mania severity measure in patients with bipolar I disorder. Pract Clin Psychol. 2018;6(3):175\u201382.","journal-title":"Pract Clin Psychol"},{"issue":"7","key":"8398_CR29","first-page":"28","volume":"4","author":"J Busner","year":"2007","unstructured":"Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4(7):28\u201337.","journal-title":"Psychiatry (Edgmont)"},{"issue":"1","key":"8398_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000493740","volume":"77","author":"E Ferensztajn-Rochowiak","year":"2019","unstructured":"Ferensztajn-Rochowiak E, Kaczmarek M, W\u00f3jcicka M, et al. Glutamate-related antibodies and peripheral insulin-like growth factor in bipolar disorder and lithium prophylaxis. Neuropsychobiology. 2019;77(1):49\u201356. https:\/\/doi.org\/10.1159\/000493740.","journal-title":"Neuropsychobiology"},{"issue":"5","key":"8398_CR31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1399-5618.2012.01028.x","volume":"14","author":"F Dickerson","year":"2012","unstructured":"Dickerson F, Stallings C, Vaughan C, Origoni A, Khushalani S, Yolken R. Antibodies to the glutamate receptor in mania. Bipolar Disord. 2012;14(5):547\u201353. https:\/\/doi.org\/10.1111\/j.1399-5618.2012.01028.x.","journal-title":"Bipolar Disord"},{"issue":"1","key":"8398_CR32","first-page":"195","volume":"1053","author":"CHUANG D-M","year":"2005","unstructured":"CHUANG D-M. The Antiapoptotic Actions of Mood Stabilizers. Ann N Y Acad Sci. 2005;1053(1):195\u2013204.","journal-title":"Ann N Y Acad Sci"},{"issue":"2\u20133","key":"8398_CR33","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.schres.2006.02.001","volume":"84","author":"L Martucci","year":"2006","unstructured":"Martucci L, Wong AH, De Luca V, Likhodi O, Wong GW, King N, et al. N-methyl-D-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: Polymorphisms and mRNA levels. Schizophr Res. 2006;84(2\u20133):214\u201321.","journal-title":"Schizophr Res"},{"issue":"2","key":"8398_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/sj.mp.4001218","volume":"8","author":"E Mundo","year":"2003","unstructured":"Mundo E, Tharmalingham S, Neves-Pereira M, Dalton EJ, Macciardi F, Parikh SV, et al. Evidence that the N-methyl-D-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder. Mol Psychiatry. 2003;8(2):241\u20135.","journal-title":"Mol Psychiatry"},{"issue":"4","key":"8398_CR35","first-page":"297","volume":"13","author":"S Dalvie","year":"2010","unstructured":"Dalvie S, Horn N, Nossek C, van der Merwe L, Stein DJ, Ramesar R. Psychosis and relapse in bipolar disorder are related to GRM3, DAOA, and GRIN2B genotype. Afr J Psychiatry (Johannesbg). 2010;13(4):297\u2013301.","journal-title":"Afr J Psychiatry (Johannesbg)"},{"issue":"7","key":"8398_CR36","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/sj.npp.1300451","volume":"29","author":"SM Clinton","year":"2004","unstructured":"Clinton SM, Meador-Woodruff JH. Abnormalities of the NMDA Receptor and Associated Intracellular Molecules in the Thalamus in Schizophrenia and Bipolar Disorder. Neuropsychopharmacology. 2004;29(7):1353\u201362.","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"8398_CR37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/0004867415586601","volume":"50","author":"B Dean","year":"2016","unstructured":"Dean B, Gibbons AS, Boer S, Uezato A, Meador-Woodruff J, Scarr E, et al. Changes in cortical N-methyl-D-aspartate receptors and post-synaptic density protein 95 in schizophrenia, mood disorders and suicide. Aust N Z J Psychiatry. 2016;50(3):275\u201383.","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"8398_CR38","first-page":"635131","volume":"2013","author":"CN Kuswanto","year":"2013","unstructured":"Kuswanto CN, Sum MY, Thng CRZ, Zhang YB, Yang GL, Nowinski WL, et al. GRIN2B Gene and Associated Brain Cortical White Matter Changes in Bipolar Disorder: A Preliminary Combined Platform Investigation. Biomed Res Int. 2013;2013(1):635131.","journal-title":"Biomed Res Int"},{"issue":"1","key":"8398_CR39","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainres.2006.09.011","volume":"1127","author":"RE McCullumsmith","year":"2007","unstructured":"McCullumsmith RE, Kristiansen LV, Beneyto M, Scarr E, Dean B, Meador-Woodruff JH. Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder. Brain Res. 2007;1127(1):108\u201318.","journal-title":"Brain Res"},{"issue":"4","key":"8398_CR40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1034\/j.1399-5618.2003.00024.x","volume":"5","author":"E Scarr","year":"2003","unstructured":"Scarr E, Pavey G, Sundram S, MacKinnon A, Dean B. Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder. Bipolar Disord. 2003;5(4):257\u201364.","journal-title":"Bipolar Disord"},{"issue":"8","key":"8398_CR41","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/bdi.13335","volume":"25","author":"F Weiss","year":"2023","unstructured":"Weiss F, Caruso V, De Rosa U, Beatino MF, Barbuti M, Nicoletti F, et al. The role of NMDA receptors in bipolar disorder: A systematic review. Bipolar Disord. 2023;25(8):624\u201336.","journal-title":"Bipolar Disord"},{"issue":"2","key":"8398_CR42","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrd1958","volume":"5","author":"SA Lipton","year":"2006","unstructured":"Lipton SA. Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond. Nat Rev Drug Discovery. 2006;5(2):160\u201370.","journal-title":"Nat Rev Drug Discovery"},{"issue":"5","key":"8398_CR43","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/cmdc.201700810","volume":"13","author":"L Temme","year":"2018","unstructured":"Temme L, Schepmann D, Schreiber JA, Frehland B, W\u00fcnsch B. Comparative Pharmacological Study of Common NMDA Receptor Open Channel Blockers Regarding Their Affinity and Functional Activity toward GluN2A and GluN2B NMDA Receptors. ChemMedChem. 2018;13(5):446\u201352.","journal-title":"ChemMedChem"},{"issue":"6","key":"8398_CR44","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0028-3908(99)00019-2","volume":"38","author":"CG Parsons","year":"1999","unstructured":"Parsons CG, Danysz W, Quack G. Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist\u2013a review of preclinical data. Neuropharmacology. 1999;38(6):735\u201367.","journal-title":"Neuropharmacology"},{"issue":"1","key":"8398_CR45","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s007260070044","volume":"19","author":"CG Parsons","year":"2000","unstructured":"Parsons CG, Danysz W, Quack G. Memantine and the amino-alkyl-cyclohexane MRZ 2\/579 are moderate affinity uncompetitive NMDA receptor antagonists\u2013in vitro characterisation. Amino Acids. 2000;19(1):157\u201366.","journal-title":"Amino Acids"},{"issue":"5","key":"8398_CR46","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00210-015-1085-6","volume":"388","author":"P Heusler","year":"2015","unstructured":"Heusler P, Tourette A, Cussac D. Potencies and unblocking kinetic properties of antagonists at recombinant human NMDA receptors in a Xenopus oocytes model. Naunyn Schmiedebergs Arch Pharmacol. 2015;388(5):509\u201316.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"6","key":"8398_CR47","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","volume":"53","author":"CG Parsons","year":"2007","unstructured":"Parsons CG, St\u00f6ffler A, Danysz W. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system\u2013too little activation is bad, too much is even worse. Neuropharmacology. 2007;53(6):699\u2013723.","journal-title":"Neuropharmacology"},{"issue":"1","key":"8398_CR48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/157015908783769671","volume":"6","author":"G Rammes","year":"2008","unstructured":"Rammes G, Danysz W, Parsons CG. Pharmacodynamics of memantine: an update. Curr Neuropharmacol. 2008;6(1):55\u201378.","journal-title":"Curr Neuropharmacol"},{"key":"8398_CR49","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.schres.2019.05.019","volume":"209","author":"W Zheng","year":"2019","unstructured":"Zheng W, Zhu XM, Zhang QE, Cai DB, Yang XH, Zhou YL, et al. Adjunctive memantine for major mental disorders: A systematic review and meta-analysis of randomized double-blind controlled trials. Schizophr Res. 2019;209:12\u201321.","journal-title":"Schizophr Res"},{"key":"8398_CR50","first-page":"148","volume":"7","author":"V Omranifard","year":"2018","unstructured":"Omranifard V, Tarrahi MJ, Sharifi S, Karahmadi M. Evaluation of the Effect of Memantine Supplementation in the Treatment of Acute Phase of Mania in Bipolar Disorder of Elderly Patients: A Double-blind Randomized Controlled Trial. Adv Biomed Res. 2018;7:148.","journal-title":"Adv Biomed Res"},{"issue":"1","key":"8398_CR51","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.4088\/JCP.13m08956","volume":"76","author":"G Serra","year":"2015","unstructured":"Serra G, Koukopoulos A, De Chiara L, Koukopoulos AE, Tondo L, Girardi P, et al. Three-year, naturalistic, mirror-image assessment of adding memantine to the treatment of 30 treatment-resistant patients with bipolar disorder. J Clin Psychiatry. 2015;76(1):e91\u20137.","journal-title":"J Clin Psychiatry"},{"issue":"1\u20132","key":"8398_CR52","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jad.2011.09.040","volume":"136","author":"A Koukopoulos","year":"2012","unstructured":"Koukopoulos A, Serra G, Koukopoulos AE, Reginaldi D, Serra G. The sustained mood-stabilizing effect of memantine in the management of treatment resistant bipolar disorders: findings from a 12-month naturalistic trial. J Affect Disord. 2012;136(1\u20132):163\u20136.","journal-title":"J Affect Disord"},{"issue":"4","key":"8398_CR53","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/WNF.0b013e318184fae2","volume":"32","author":"PE Keck Jr","year":"2009","unstructured":"Keck PE Jr., Hsu HA, Papadakis K, Russo J. Jr. Memantine efficacy and safety in patients with acute mania associated with bipolar I disorder: a pilot evaluation. Clin Neuropharmacol. 2009;32(4):199\u2013204.","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"8398_CR54","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1399-5618.2011.00971.x","volume":"14","author":"A Anand","year":"2012","unstructured":"Anand A, Gunn AD, Barkay G, Karne HS, Nurnberger JI, Mathew SJ, et al. Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial. Bipolar Disord. 2012;14(1):64\u201370.","journal-title":"Bipolar Disord"},{"key":"8398_CR55","doi-asserted-by":"crossref","unstructured":"Krzystanek M, Surma S, Pa\u0142asz A, Roma\u0144czyk M, Krysta K. Possible antidepressant effects of memantine-systematic review with a case study. Pharmaceuticals (Basel). 2021;14(5).","DOI":"10.3390\/ph14050481"},{"issue":"2","key":"8398_CR56","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/JCP.0000000000000651","volume":"37","author":"A Sahraian","year":"2017","unstructured":"Sahraian A, Jahromi LR, Ghanizadeh A, Mowla A. Memantine as an Adjuvant Treatment for Obsessive Compulsive Symptoms in Manic Phase of Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J Clin Psychopharmacol. 2017;37(2):246\u20139.","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"8398_CR57","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/JCP.0000000000000109","volume":"34","author":"SY Lee","year":"2014","unstructured":"Lee SY, Chen SL, Chang YH, Chen PS, Huang SY, Tzeng NS, et al. The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: a 12-week double-blind, randomized controlled trial. J Clin Psychopharmacol. 2014;34(3):337\u201343.","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"8398_CR58","first-page":"474","volume":"122","author":"R Zahorec","year":"2021","unstructured":"Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy. 2021;122(7):474\u201388.","journal-title":"Bratisl Lek Listy"},{"key":"8398_CR59","unstructured":"Mank V, Azhar W, Brown K. Leukocytosis. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2025. StatPearls Publishing LLC; 2025."},{"key":"8398_CR60","doi-asserted-by":"crossref","unstructured":"Rybakowski JK. Mood stabilizers of first and second generation. Brain Sci. 2023;13(5).","DOI":"10.3390\/brainsci13050741"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-08398-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08398-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08398-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:56:33Z","timestamp":1792061793000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-08398-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8398"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-08398-y","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Institutional Review Board and Ethics Committee of Shiraz University of Medical Sciences (Approval Code: IR.SUMS.MED.REC.1403.783). The study was conducted in accordance with the ethical principles of the Declaration of Helsinki and its later amendments. The trial was registered in the Iranian Registry of Clinical Trials (IRCT20250430065539N1). All participants provided written informed consent prior to enrollment.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"792"}}